Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,075.00    -515.00 (-9.21%)
Bid:
5,060.00
Ask:
5,065.00
Spread: 5.00 (0.099%)
Market Cap: $1.33t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Charitable Contribution

16 Feb 2021 08:31

RNS Number : 2364P
Samsung Electronics Co. Ld
16 February 2021
 

Charitable Contribution

 

The Board of Directors of Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD)

("SEC") on February 16, 2021 authorized the following: (i) management plan for the Social

Contribution Matching Fund for 2021 and (ii) contribution to the Chungnam Samsung Academy.

 

Management Plans for the Social Contribution Matching Fund for 2021

- The Social Contribution Fund consists of voluntary contributions by employees with matching funds

from SEC. SEC plans to contribute KRW 11.61 billion in 2021 to match the funds raised by

employees last year.

 

- SEC's contributions will be used for social contribution activities related to youth education and

assistance for vulnerable members of the population.

 

Contribution to Chungnam Samsung Academy

- SEC will contribute KRW 2.446 billion in early March, 2021 to Chungnam Samsung Academy as

a part of its efforts to (i) attract talented employees by improving the learning environment for the

school-aged children of such employees and (ii) improve the local education infrastructure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKABBFBKKCBD
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
31st Jul 20247:00 amRNS2024 2Q Earnings Release
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.